Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0042373|vascular disease
Sentences 78
PubMedID- 25541285 The insulin-like growth factor i system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome.
PubMedID- 21808142 Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm).
PubMedID- 24498934 Furthermore, in concordance with studies performed in healthy individuals [37], we observed a strong relation between ev-cystatin c and the metabolic syndrome in patients with clinically manifest vascular disease.
PubMedID- 23199128 In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese.
PubMedID- 21123363 The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism.
PubMedID- 24788056 The most common conditions for which genetic counseling was provided were hypertrophic cardiomyopathy (hcm) (71% of participants), dilated cardiomyopathy (dcm) (61%), long qt syndrome (lqts) (56%), and genetic syndromes with cardiovascular disease (55%).
PubMedID- 22205060 The emphasis on diagnosing and treating the individual risk factors should help in the prevention of the cardiovascular disease associated with obesity, the metabolic syndrome and type 2 diabetes.
PubMedID- 25918936 The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation [2,5].
PubMedID- 25228949 Furthermore, metabolic syndrome is associated with vascular diseases including ph.
PubMedID- 24708775 In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia [32,37].
PubMedID- 21130454 Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins.
PubMedID- 21654497 In the univariate analysis, variables significantly associated with hypertension were age, waist circumference, established cardiovascular disease, family history of hypertension, lipoatrophy, metabolic syndrome, duration of infection, cd4 nadir, hiv rna <50 copies/ml, and antiretroviral treatment.
PubMedID- 22417460 High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components.
PubMedID- 23257741 [chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
PubMedID- 20300596 Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (mets).
PubMedID- 20553596 Given the prognostic significance of the metabolic syndrome in patients with vascular disease, we evaluated the association of vfa, sfa and lfp with metabolic syndrome in a high-risk vascular cohort.
PubMedID- 24705461 Aids-related lymphoma (arl), metabolic syndromes (including cardiovascular diseases, cvds; atherosclerosis and other lipid disorders), and hiv-associated dementia (had) – can be considered as all macrophage-mediated disorders in which nef is an unquestioned key factor [10].
PubMedID- 24844874 Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn).
PubMedID- 24445696 Conclusion: in this small study, metabolic syndrome was found to be more frequently identified in turkish patients with psoriasis than in controls; metabolic syndrome could lead to increased cardiovascular disease risk in patients with moderate to severe psoriasis.
PubMedID- 24553695 Dietary echium oil increases long-chain n-3 pufas, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome.
PubMedID- 26485682 Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4].
PubMedID- 22682107 Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit.
PubMedID- 22966233 Therefore, careful consideration of the preoperative angiographical findings and cerebrovascular reserve capacity would be vital for determining the indication of indirect revascularization surgery for moyamoya syndrome complicated with systemic progressive vascular disease.
PubMedID- 21766575 [the association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study].
PubMedID- 25957218 Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease.
PubMedID- 20823276 Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome.
PubMedID- 23334870 This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting.
PubMedID- 22424625 Objective: the association of metabolic syndrome (mets) with cardiovascular diseases (cvd) has not been adequately explored in middle-aged and elderly chinese.
PubMedID- 23524050 The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease.
PubMedID- 22121272 Although metabolic syndrome leads to cardiovascular disease, psoriasis might be an independent risk factor for hypertension and cardiovascular disease even after correction for metabolic syndrome components.
PubMedID- 24624345 Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome [4], is associated with kidney disease, cardiovascular disease [5], cerebrovascular disease [6], obesity, diabetes, hypertriglyceridemia, and hypertension.
PubMedID- 24926685 Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome.
PubMedID- 22877354 Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular disease and prevalence of metabolic syndrome in middle-aged men.
PubMedID- 24396692 Furthermore, nafld is emerging as a risk factor for diabetes and cardiovascular disease, independently of insulin resistance, metabolic syndrome, plasma lipid level, and other traditional risk factors [2].
PubMedID- 23323622 Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
PubMedID- 21466628 Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable.
PubMedID- 25916279 Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome.
PubMedID- 20488778 In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome.
PubMedID- 20349347 The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities.
PubMedID- 21318102 Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome.
PubMedID- 25857370 Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases.
PubMedID- 24856006 Objectives since oils and fats can induce metabolic syndrome, leading to cardiovascular and cerebrovascular diseases, the present study was performed to find out whether the plant oils affect the cerebral hemorrhage in stroke-prone spontaneously hypertensive (shr-sp) rats.
PubMedID- 21122628 Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c).
PubMedID- 22123633 There seems to be an inverse relation between 25(oh)d serum concentrations and cardiovascular diseases, some components of the metabolic syndrome, and physical fitness.
PubMedID- 23873328 Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure.
PubMedID- 22359422 The metabolic syndrome among patients with cardiovascular disease in accra, ghana.
PubMedID- 20508159 The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using jcr:la-cp rats.
PubMedID- 23306779 Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome.
PubMedID- 20689417 Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease.
PubMedID- 21845221 Nafld is becoming a risk factor for diabetes and cardiovascular diseases (cvds) independently of insulin resistance, metabolic syndrome, plasma lipid levels, and other usual risk factors [3, 4].

Page: 1 2